Related Experiment Video
Updated: Jul 18, 2026
Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Coronary artery bypass grafting in idiopathic myelofibrosis: a case report
Selim C Isbir1, Koray Ak, Atike Tekeli
1Department of Cardiovascular Surgery, Marmara University Hospital, Istanbul, Turkey.
Insights
Patients with myeloproliferative disorders, like idiopathic myelofibrosis, face surgical challenges. This report details a successful coronary artery bypass surgery in such a patient, highlighting effective management strategies.
Area of Science:
- Cardiology
- Hematology
- Surgical Oncology
Background:
- Myeloproliferative disorders (MPDs) present unique challenges for patients requiring cardiac surgery.
- The risk of thrombosis and hemorrhage complicates surgical management in MPD patients.
Observation:
- A patient with idiopathic myelofibrosis (IMF), a type of MPD, required coronary artery bypass surgery (CABS).
Findings:
- The patient successfully underwent CABS despite the complexities associated with IMF.
- Perioperative management strategies were crucial for achieving a positive surgical outcome.
Implications:
- This case demonstrates the feasibility of CABS in selected patients with IMF.
- Further research into optimized perioperative protocols for MPD patients undergoing major surgery is warranted.
Abstract:
The concomitant presence of myeloproliferative disorders and the need for coronary artery bypass surgery is a surgical dilemma. Thrombosis and hemorrhage can cause difficult problems and might require different approaches during and after surgery. We report a patient who had idiopathic myelofibrosis and underwent a successful coronary artery bypass surgery.
